59.98
0.00
(0.00%)
As of January 31 at 8:43:02 AM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 20 | 17 | 25 | 25 |
| Avg. Estimate | 2.29B | 2.18B | 8.41B | 9.28B |
| Low Estimate | 2.15B | 2.1B | 8.28B | 8.54B |
| High Estimate | 2.35B | 2.24B | 8.47B | 9.49B |
| Year Ago Sales | 1.82B | 1.74B | 7.02B | 8.41B |
| Sales Growth (year/est) | 25.85% | 25.50% | 19.71% | 10.37% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 0R6.F | -- | -- | -- | -- |
| S&P 500 | 10.39% | 9.41% | 13.53% | 14.03% |
Upgrades & Downgrades
| Upgrade | Guggenheim: Neutral to Buy | 1/24/2025 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 1/21/2025 |
| Maintains | Stifel: Hold to Hold | 1/10/2025 |
| Maintains | Oppenheimer: Outperform to Outperform | 1/7/2025 |
| Maintains | Stifel: Hold to Hold | 11/14/2024 |
| Maintains | Argus Research: Buy to Buy | 11/7/2024 |